Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.385 USD | +1.96% | +10.49% | +4.66% |
14/05 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
14/05 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.66% | 236M | |
+7.00% | 113B | |
+10.97% | 106B | |
+0.61% | 22.27B | |
-12.34% | 22.22B | |
-5.20% | 19.43B | |
-37.85% | 17.87B | |
-6.18% | 17.24B | |
+7.88% | 14.29B | |
+34.81% | 12.52B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics : Ladenburg Thalmann Adjusts Price Target on Ovid Therapeutics to $7 From $21, Maintains Buy Rating